Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Vitamin D on Graft-versus-Host Disease.
Rodríguez-Gil A, Carrillo-Cruz E, Marrero-Cepeda C, Rodríguez G, Pérez-Simón JA. Rodríguez-Gil A, et al. Biomedicines. 2022 Apr 24;10(5):987. doi: 10.3390/biomedicines10050987. Biomedicines. 2022. PMID: 35625724 Free PMC article. Review.
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms.
Carrillo-Cruz E, García-Lozano JR, Márquez-Malaver FJ, Sánchez-Guijo FM, Montero Cuadrado I, Ferra I Coll C, Valcárcel D, López-Godino O, Cuesta M, Parody R, López-Corral L, Alcoceba M, Caballero-Velázquez T, Rodríguez-Gil A, Bejarano-García JA, Ramos TL, Pérez-Simón JA. Carrillo-Cruz E, et al. Among authors: rodriguez gil a. Clin Cancer Res. 2019 Aug 1;25(15):4616-4623. doi: 10.1158/1078-0432.CCR-18-3875. Epub 2019 May 1. Clin Cancer Res. 2019. PMID: 31043390 Free article. Clinical Trial.
Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
Ramos TL, García-Guerrero E, Caballero-Velázquez T, Rodríguez-Gil A, Caracuel-García R, Nufer M, Robles-Frías MJ, Barbado MV, Pérez-Simón JA. Ramos TL, et al. Among authors: rodriguez gil a. Bone Marrow Transplant. 2021 Dec;56(12):3049-3058. doi: 10.1038/s41409-021-01452-1. Epub 2021 Sep 23. Bone Marrow Transplant. 2021. PMID: 34556806 Free PMC article.
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Rodríguez-Gil A, Escamilla-Gómez V, Nufer M, Andújar-Sánchez F, Lopes-Ramos T, Bejarano-García JA, García-Guerrero E, Calderón-Cabrera C, Caballero-Velázquez T, García-Calderón CB, Hernández-Díaz P, Reguera-Ortega JL, Rodríguez-Torres N, Martínez-Cibrián N, Rodríguez-Barbosa JI, Villadiego J, Pérez-Simón JA. Rodríguez-Gil A, et al. Sci Rep. 2022 May 19;12(1):8348. doi: 10.1038/s41598-022-12407-x. Sci Rep. 2022. PMID: 35589917 Free PMC article.
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.
García-Guerrero E, Götz R, Doose S, Sauer M, Rodríguez-Gil A, Nerreter T, Kortüm KM, Pérez-Simón JA, Einsele H, Hudecek M, Danhof S. García-Guerrero E, et al. Among authors: rodriguez gil a. Leukemia. 2021 Jan;35(1):201-214. doi: 10.1038/s41375-020-0840-y. Epub 2020 Apr 29. Leukemia. 2021. PMID: 32350373 Free PMC article.
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.
García-Guerrero E, Götz R, Doose S, Sauer M, Rodríguez-Gil A, Nerreter T, Kortüm KM, Pérez-Simón JA, Einsele H, Hudecek M, Danhof S. García-Guerrero E, et al. Among authors: rodriguez gil a. Leukemia. 2022 Jan;36(1):297. doi: 10.1038/s41375-021-01355-6. Leukemia. 2022. PMID: 34845317 Free PMC article. No abstract available.
25 results